Elisa Picardo Selected Research

Biomarkers (Surrogate Marker)

2/2023

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Picardo Research Topics

Disease

3	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 09/2013
2	Neoplasms (Cancer) 01/2023 - 12/2021
1	Triple Negative Breast Neoplasms 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 02/2022
1	Leiomyoma (Uterine Fibroids) 02/2022
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2018
1	Thalassemia 01/2016
1	Ovarian Epithelial Carcinoma 09/2013
1	Headache (Headaches) 04/2012
1	Birth Weight (Birth Weights) 04/2012
1	Hemolysis 01/2011
1	HELLP Syndrome 01/2011
1	Pre-Eclampsia (Preeclampsia) 01/2011

Drug/Important Bio-Agent (IBA)

2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 02/2023
2	PlatinumIBA 12/2023 - 02/2023
2	EnzymesIBA 09/2013 - 01/2011
1	TrabectedinIBA 12/2023
1	1-dodecylpyridoxal (PLD)IBA 12/2023
1	liposomal doxorubicin (Doxil)FDA Link 12/2023
1	Biomarkers (Surrogate Marker)IBA 02/2023
1	Capecitabine (Xeloda)FDA Link 01/2023
1	Antiphospholipid AntibodiesIBA 01/2018
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 09/2013
1	ImmunosorbentsIBA 09/2013
1	Carboplatin (JM8)FDA LinkGeneric 09/2013

Therapy/Procedure

2	Therapeutics 12/2023 - 01/2016
1	Neoadjuvant Therapy 01/2023
1	Uterine Myomectomy 02/2022
1	Morcellation 02/2022
1	Hysterectomy 02/2022
1	Critical Care (Surgical Intensive Care) 12/2021
1	Cesarean Section (Caesarean Section) 04/2012